Penumbra Shares Surge on Boston Scientific Acquisition Deal
Penumbra Inc. stock reached a record high after Boston Scientific announced a $14.5 billion acquisition agreement. The deal is expected to close in 2026.
Topic
Latest reporting and analysis tagged with acquisition.
Penumbra Inc. stock reached a record high after Boston Scientific announced a $14.5 billion acquisition agreement. The deal is expected to close in 2026.
Wolfe Research downgraded Ryder System to Peer Perform on January 8, shortly after the company completed its acquisition of Truck Service Depot on January 5.
Westlake Corporation completed its acquisition of ACI/Perplastic Group's compounding businesses on January 5. On January 8, BofA analyst Matthew DeYoe lowered Westlake's price target to $82 from $83 while maintaining a Buy rating.
The Toro Company has finalized its C$279 million acquisition of Tornado Infrastructure Equipment. Baird raised its price target on Toro to $86 following the company's Q4 results.
Eli Lilly's Taltz and Zepbound show superior efficacy in a Phase 3b trial for psoriatic arthritis and obesity. The company also agreed to acquire Ventyx Biosciences for about $1.2 billion.
HF Sinclair Corporation has finalized its $38 million acquisition of Industrial Oils Unlimited, a move that strengthens its lubricants and specialties segment. The company also received a stock upgrade from Piper Sandler analyst Ryan Todd on the same day.
Jim Cramer discussed Kimberly-Clark's planned $49 billion acquisition of Kenvue on his November 20, 2025 show, commenting on the stock's performance and yield.
Jim Cramer commented on a caller's Dynavax stock purchase after Sanofi's $2.2 billion acquisition announcement. CEO Ryan Spencer stated the deal advances their mission.
Oakmark Fund's Q4 2025 letter reported a 4.78% return, beating the S&P 500. It highlighted Warner Bros. Discovery as a top performer amid acquisition offers.